200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 18920-47-3
18920-47-3 | Furo[3',4':6,7]naphtho[1,2-d]-1,3-dioxol-7(9H)-one, 10-(1,3-benzodioxol-5-yl)-
CAS No: 18920-47-3 Catalog No: AG002I2D MDL No:
Product Description
Catalog Number:
AG002I2D
Chemical Name:
Furo[3',4':6,7]naphtho[1,2-d]-1,3-dioxol-7(9H)-one, 10-(1,3-benzodioxol-5-yl)-
CAS Number:
18920-47-3
Molecular Formula:
C20H12O6
Molecular Weight:
348.3057
IUPAC Name:
10-(1,3-benzodioxol-5-yl)-9H-[2]benzofuro[6,5-g][1,3]benzodioxol-7-one
InChI:
InChI=1S/C20H12O6/c21-20-12-5-10-2-4-15-19(26-9-24-15)18(10)17(13(12)7-22-20)11-1-3-14-16(6-11)25-8-23-14/h1-6H,7-9H2
InChI Key:
JUBRYHUFFFYTGR-UHFFFAOYSA-N
SMILES:
O=C1OCc2c1cc1ccc3c(c1c2c1ccc2c(c1)OCO2)OCO3
Properties
Complexity:
581
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
348.063g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
348.31g/mol
Monoisotopic Mass:
348.063g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
63.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.8
Literature
| Title | Journal |
|---|---|
| Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice. | Environmental toxicology 20161201 |
| Arylnaphthalene lignans from Taiwania cryptomerioides as novel blockers of voltage-gated K+ channels. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20101215 |
| Enhancement of bone formation ex vivo and in vivo by a helioxanthin-derivative. | Biochemical and biophysical research communications 20100514 |
| Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents. | Bioorganic & medicinal chemistry 20100201 |
| Icariin: a potential osteoinductive compound for bone tissue engineering. | Tissue engineering. Part A 20100101 |
| Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture. | Antiviral chemistry & chemotherapy 20100101 |
| Synthesis and antiviral activity of helioxanthin analogues. | Journal of medicinal chemistry 20050127 |
| Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative. | Antiviral chemistry & chemotherapy 20050101 |
Related Products
© 2019 Angene International Limited. All rights Reserved.